In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Society of Retina Specialists annual meeting, as well as Healio’s top headlines from the meeting.

Andrew G. Lee, MD, discusses when retina experts should refer patients to a neuro-ophthalmologist. 0:29

Sunir J. Garg, MD, FACS, FASRS, provides an overview of lessons learned from two complex surgical cases. 1:52

Sunir J. Garg, MD, FACS, FASRS, overviewed key findings from the Global Trends in Retina Survey. 5:16

Michael O’Rouke talks collaborating with Boehringer Ingelheim to develop extended-release therapies for ophthalmic diseases. 8:17

Jay S. Duker, MD, discusses EyePoint Pharmaceuticals’ second phase 3 trial of Duravyu in patients with wet age-related macular degeneration. 11:08

Read the full coverage here:

https://www.healio.com/news/ophthalmology/20250731/andrew-g-lee-shares-neuroophthalmology-advice-for-retina-specialists

https://www.healio.com/news/ophthalmology/20250731/sunir-garg-shares-solutions-to-complex-surgical-cases

https://www.healio.com/news/ophthalmology/20250730/revana-collaborates-with-boehringer-ingelheim-to-develop-extendedrelease-therapies

https://www.healio.com/news/ophthalmology/20250807/eyepoint-completes-enrollment-in-second-phase-3-trial-of-sustainedrelease-amd-therapy

https://www.healio.com/news/ophthalmology/20250811/survey-treatment-for-recalcitrant-diabetic-macular-edema-varies-between-us-europe

Long-term benefits seen with Gore-Tex sutures for scleral fixation of IOLs

Source: Acaba-Berrocal L, et al. Long-term outcomes of pars plana vitrectomy and polytetrafluoroethylene sutured scleral-fixated intraocular lenses. Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California.

Study supports Iluvien as ‘long-acting option’ in diabetic macular edema

Source: Singer MA, et al. NEW DAY: Study design, study sites, patient enrollment: A study of intravitreal Iluvien (fluocinolone acetonide) implant as baseline therapy in patients with early diabetic macular edema (DME) (NEW DAY). Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California.

Disclosures:

Duker reports being president and CEO of EyePoint Pharmaceuticals. Garg reports no relevant financial disclosures. Lee reports no relevant financial disclosures. O’Rourke reports being CEO of Re-Vana Therapeutics.